Both neurogenic and vascular causes of primary headache;Både neurogena och vaskulära orsaker bakom primär huvudvärk

Lakartidningen

Volumn 98, Issue 39, 2001, Pages 4176-4183

  Edvinsson, Lars ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CALCIUM CHANNEL; SEROTONIN RECEPTOR;

ADRENERGIC SYSTEM; BLOOD; BRAIN CIRCULATION; CHOLINERGIC SYSTEM; CLUSTER HEADACHE; DRUG EFFECT; HEADACHE AND FACIAL PAIN; HUMAN; MEDICAL ILLUSTRATION; METABOLISM; MIGRAINE; PATHOPHYSIOLOGY; REVIEW; SECRETION; SENSORY RECEPTOR; TRIGEMINUS NEURALGIA; VASOCONSTRICTION; VASODILATATION;

CALCIUM CHANNELS; CEREBROVASCULAR CIRCULATION; CLUSTER HEADACHE; HEADACHE DISORDERS; HUMANS; MEDICAL ILLUSTRATION; MIGRAINE DISORDERS; NEUROTRANSMITTER AGENTS; PARASYMPATHETIC NERVOUS SYSTEM; RECEPTORS, SENSORY; RECEPTORS, SEROTONIN; SYMPATHETIC NERVOUS SYSTEM; TRIGEMINAL NEURALGIA; VASOCONSTRICTION; VASODILATION;

EID: 18544395052     PISSN: 00237205     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ray BS, Wolff HG. Experimental studies on headaches, pain sensitive structures of the head and their significance in headaches. Arch Surg 1940;41:813-56.
2. Fanciullacci M, Alessandri M, Figini M, Geppetti P, Michelacci S. Increases in plasma calcitonin gene-related peptide from extracerebral circulation during nitroglycerin-induced cluster attack. Pain 1995;60:119-23.
3. McCulloch J, Uddman R, Kingman TA, Edvinsson L. Calcitonin gene-related peptide. Functional role in cerebrovascular regulation. Proc Natl Acad Sci USA 1986;83:5731-5.
4. Goadsby PJ, Edvinsson L , Ekman R. Vasoactive peptide release in the extracerebral circulation of human during migraine headache. Ann Neurol 1990;28:183-97.
5. Gallai V, Sarchielli P, Floridi A, Franceschini M, Codini M, Glioti G, et al. Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia 1995;15:384-90.
6. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993;33:48-56.
7. Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain 1994;117:427-34.
8. Goadsby PJ, Edvinsson L, Ekman R. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 1988;23:193-6.
9. Goadsby PJ, Edvinsson L, Ekman R. Cutaneous sensory stimulation leading to facial flushing and release of calcitonin gene-related peptide. Cephalalgia 1992;12:53-6
10. Goadsby PJ, Edvinsson L. Neuropeptide changes in a case of chronic paroxysmal hemicrania: evidence for trigemino-parasympathetic activation. Cephalalgia 1996;16:448-50.
11. Goadsby PJ, Edvinsson L. Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (HT)-ID receptor agonist 311C90. Headache 1994;34:394-9.
12. 2+ channel gene CACNL1A4. Cell 1996;87:543-52.
13. Weiller C, May A, Limmroth V, Jüptner M, Kaube H, Schayak RV, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995;1:658-60.
14. Olesen J, Friberg L, Skyhöj Olsen T. Timing and topography of cerebral blood flow, aura and headache during migraine attacks. Ann Neurol 1990;28:791-8.
15. Woods RP, Iacoboni M, Mazziotta JC. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Eng Med 1994;31:1689-92.
16. May A, Bahra A, Büchel C, Frackowiak RSJ, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet 1998;351:275-8.
17. May A, Kaube H, Buchel C, Eichten C, Rijntjes M, Juptner M, et al. Experimental cranial pain elicited by capsaicin: a PET study. Pain 1998;74:61-6.
18. Nilsson T, Longmore J, Shaw D, Jansen-Olesen I, Edvinsson L. Contractile 5-HT1B receptors in human cerebral arteries. Pharmacological characterization and localisation with immunocytochemistry. Br J Pharmacol 1999;128:1133-40.
19. Longmore J, Shaw D, Smith D, Hopkins R, McAllister G, Pickard JD, et al. Differential distribution of 5-HT1B and 5-HT1D immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs. Cephalalgia 1997;17:833-42.